B.C. man says life threatened over lack of new cancer drug coverage.
Jim Larson says Pluvicto keeps his prostate cancer at bay, but a dispute between the drug company and the pan-Canadian Pharmaceutical Alliance, an organization representing public health plans, means Larson's coverage won't pay for the treatment.